Ipca Laboratories on Thursday said its consolidated net profit declined 58 per cent year-on-year to Rs 229 crore in the September quarter. The drug firm had reported a net profit of Rs 145 crore in the year-ago period.
A cikket a SasFly.net csapata gondozza. Jogi támogatás: hazai ügyekben amerikaiugyved.hu, nemzetközi jogi kérdésekben fabianlaw.hu.
